Cargando…

Evolution of Clinical Phenotypes of COVID-19 Patients During Intensive Care Treatment: An Unsupervised Machine Learning Analysis

BACKGROUND: Identification of clinical phenotypes in critically ill COVID-19 patients could improve understanding of the disease heterogeneity and enable prognostic and predictive enrichment. However, previous attempts did not take into account temporal dynamics with high granularity. By including t...

Descripción completa

Detalles Bibliográficos
Autores principales: Siepel, Sander, Dam, Tariq A., Fleuren, Lucas M., Girbes, Armand R.J., Hoogendoorn, Mark, Thoral, Patrick J., Elbers, Paul W.G., Bennis, Frank C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902809/
https://www.ncbi.nlm.nih.gov/pubmed/36744415
http://dx.doi.org/10.1177/08850666231153393
_version_ 1784883341928955904
author Siepel, Sander
Dam, Tariq A.
Fleuren, Lucas M.
Girbes, Armand R.J.
Hoogendoorn, Mark
Thoral, Patrick J.
Elbers, Paul W.G.
Bennis, Frank C.
author_facet Siepel, Sander
Dam, Tariq A.
Fleuren, Lucas M.
Girbes, Armand R.J.
Hoogendoorn, Mark
Thoral, Patrick J.
Elbers, Paul W.G.
Bennis, Frank C.
author_sort Siepel, Sander
collection PubMed
description BACKGROUND: Identification of clinical phenotypes in critically ill COVID-19 patients could improve understanding of the disease heterogeneity and enable prognostic and predictive enrichment. However, previous attempts did not take into account temporal dynamics with high granularity. By including the dimension of time, we aim to gain further insights into the heterogeneity of COVID-19. METHODS: We used granular data from 3202 adult COVID patients in the Dutch Data Warehouse that were admitted to one of 25 Dutch ICUs between February 2020 and March 2021. Parameters including demographics, clinical observations, medications, laboratory values, vital signs, and data from life support devices were selected. Twenty-one datasets were created that each covered 24 h of ICU data for each day of ICU treatment. Clinical phenotypes in each dataset were identified by performing cluster analyses. Both evolution of the clinical phenotypes over time and patient allocation to these clusters over time were tracked. RESULTS: The final patient cohort consisted of 2438 COVID-19 patients with a ICU mortality outcome. Forty-one parameters were chosen for cluster analysis. On admission, both a mild and a severe clinical phenotype were found. After day 4, the severe phenotype split into an intermediate and a severe phenotype for 11 consecutive days. Heterogeneity between phenotypes appears to be driven by inflammation and dead space ventilation. During the 21-day period, only 8.2% and 4.6% of patients in the initial mild and severe clusters remained assigned to the same phenotype respectively. The clinical phenotype half-life was between 5 and 6 days for the mild and severe phenotypes, and about 3 days for the medium severe phenotype. CONCLUSIONS: Patients typically do not remain in the same cluster throughout intensive care treatment. This may have important implications for prognostic or predictive enrichment. Prominent dissimilarities between clinical phenotypes are predominantly driven by inflammation and dead space ventilation.
format Online
Article
Text
id pubmed-9902809
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-99028092023-02-07 Evolution of Clinical Phenotypes of COVID-19 Patients During Intensive Care Treatment: An Unsupervised Machine Learning Analysis Siepel, Sander Dam, Tariq A. Fleuren, Lucas M. Girbes, Armand R.J. Hoogendoorn, Mark Thoral, Patrick J. Elbers, Paul W.G. Bennis, Frank C. J Intensive Care Med Original Research BACKGROUND: Identification of clinical phenotypes in critically ill COVID-19 patients could improve understanding of the disease heterogeneity and enable prognostic and predictive enrichment. However, previous attempts did not take into account temporal dynamics with high granularity. By including the dimension of time, we aim to gain further insights into the heterogeneity of COVID-19. METHODS: We used granular data from 3202 adult COVID patients in the Dutch Data Warehouse that were admitted to one of 25 Dutch ICUs between February 2020 and March 2021. Parameters including demographics, clinical observations, medications, laboratory values, vital signs, and data from life support devices were selected. Twenty-one datasets were created that each covered 24 h of ICU data for each day of ICU treatment. Clinical phenotypes in each dataset were identified by performing cluster analyses. Both evolution of the clinical phenotypes over time and patient allocation to these clusters over time were tracked. RESULTS: The final patient cohort consisted of 2438 COVID-19 patients with a ICU mortality outcome. Forty-one parameters were chosen for cluster analysis. On admission, both a mild and a severe clinical phenotype were found. After day 4, the severe phenotype split into an intermediate and a severe phenotype for 11 consecutive days. Heterogeneity between phenotypes appears to be driven by inflammation and dead space ventilation. During the 21-day period, only 8.2% and 4.6% of patients in the initial mild and severe clusters remained assigned to the same phenotype respectively. The clinical phenotype half-life was between 5 and 6 days for the mild and severe phenotypes, and about 3 days for the medium severe phenotype. CONCLUSIONS: Patients typically do not remain in the same cluster throughout intensive care treatment. This may have important implications for prognostic or predictive enrichment. Prominent dissimilarities between clinical phenotypes are predominantly driven by inflammation and dead space ventilation. SAGE Publications 2023-02-06 2023-07 /pmc/articles/PMC9902809/ /pubmed/36744415 http://dx.doi.org/10.1177/08850666231153393 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
Siepel, Sander
Dam, Tariq A.
Fleuren, Lucas M.
Girbes, Armand R.J.
Hoogendoorn, Mark
Thoral, Patrick J.
Elbers, Paul W.G.
Bennis, Frank C.
Evolution of Clinical Phenotypes of COVID-19 Patients During Intensive Care Treatment: An Unsupervised Machine Learning Analysis
title Evolution of Clinical Phenotypes of COVID-19 Patients During Intensive Care Treatment: An Unsupervised Machine Learning Analysis
title_full Evolution of Clinical Phenotypes of COVID-19 Patients During Intensive Care Treatment: An Unsupervised Machine Learning Analysis
title_fullStr Evolution of Clinical Phenotypes of COVID-19 Patients During Intensive Care Treatment: An Unsupervised Machine Learning Analysis
title_full_unstemmed Evolution of Clinical Phenotypes of COVID-19 Patients During Intensive Care Treatment: An Unsupervised Machine Learning Analysis
title_short Evolution of Clinical Phenotypes of COVID-19 Patients During Intensive Care Treatment: An Unsupervised Machine Learning Analysis
title_sort evolution of clinical phenotypes of covid-19 patients during intensive care treatment: an unsupervised machine learning analysis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902809/
https://www.ncbi.nlm.nih.gov/pubmed/36744415
http://dx.doi.org/10.1177/08850666231153393
work_keys_str_mv AT siepelsander evolutionofclinicalphenotypesofcovid19patientsduringintensivecaretreatmentanunsupervisedmachinelearninganalysis
AT damtariqa evolutionofclinicalphenotypesofcovid19patientsduringintensivecaretreatmentanunsupervisedmachinelearninganalysis
AT fleurenlucasm evolutionofclinicalphenotypesofcovid19patientsduringintensivecaretreatmentanunsupervisedmachinelearninganalysis
AT girbesarmandrj evolutionofclinicalphenotypesofcovid19patientsduringintensivecaretreatmentanunsupervisedmachinelearninganalysis
AT hoogendoornmark evolutionofclinicalphenotypesofcovid19patientsduringintensivecaretreatmentanunsupervisedmachinelearninganalysis
AT thoralpatrickj evolutionofclinicalphenotypesofcovid19patientsduringintensivecaretreatmentanunsupervisedmachinelearninganalysis
AT elberspaulwg evolutionofclinicalphenotypesofcovid19patientsduringintensivecaretreatmentanunsupervisedmachinelearninganalysis
AT bennisfrankc evolutionofclinicalphenotypesofcovid19patientsduringintensivecaretreatmentanunsupervisedmachinelearninganalysis
AT evolutionofclinicalphenotypesofcovid19patientsduringintensivecaretreatmentanunsupervisedmachinelearninganalysis